参考文献/References:
[1] Koukourakis MI, Giatromanolaki A, Sivridis E, et al. Cancer vascularization:implications in radiotherapy?[J]. Int J Radiat Oncol Biol Phys, 2000, 48(2):545-553.
[2] Scandurro AB, Weldon CW, Figueroa YG, et al. Gene microarray analysis reveals a novel hypoxia signal transduction pathway in human hepatocellular carcinoma cells[J]. Int J Oncol, 2001, 19(1):129-135.
[3] Krause B J, Beck R, Souvatzoglou M, et al. PET and PET/CT studies of tumor tissue oxygenation[J]. Q J Nucl Med Mol Imaging, 2006, 50(1):28-43.
[4] Bentzen L, Keiding S, Horsman MR. Assessment of hypoxia in experimental mice tumours by 18F-Fluoromisonidazole PET and pO2 electrode measurements. Influence of tumour rolume and carbogen berathing[J]. Acta Oncol, 2002, 41(3):304-312.
[5] Lehtiö K, Oikonen V, Nyman S, et al. Quantifying tumor hypoxia with fluorine-18 fluoroerythronitroimidazole (18F-FETNIM)and PET using the tumor to plasma ratio[J]. Eur J Nucl Med Mol Imaging, 2003, 30(1):101-108.
[6] Piert M, Machulla HJ, Picchio M, et al. Hypoxia-specific tumor imaging with 18F-fluoroazomycin arabinoside[J]. J Nucl Med, 2005, 46(1):106-113.
[7] Ziemer LS, Evans SM, Kachur AV, et al. Noninvasive imaging of tumor hypoxia in rats using the 2-nitroimidazole 18F-EF5[J]. Eur J Nucl Med Mol Imaging, 2003, 30(2):259-266.
[8] Siim BG, Laux WT, Rutland MD, et al. Scintigraphic imaging of the hypoxia marker (99m)technetium-labeled 2, 2,-(1, 4-diaminobutane) bis(2-methyl-3-butanone) dioxime (99m Tc-labeled HL91; Prognox):non-invasive detection of tumor response to the antivaseular agent 5, 6-dimethyl 2000, 60(16):4582-4588.
[9] Rasey JS, Koh WJ, Evans ML, et al. Quantifying regional hypoxia in human tumors with positron emission tomography of[18F] fluoromisonidazole:a pretherapy study of 37 patients[J]. Int J Radiat Oncol Biol Phys, 1996, 36(2):417-428.1
[10] Dehdashti F, Mintun MA, Lewis JS, et al. In vivo assessment of tumor hypoxia in lung cancer with 60Cu-ATSM[J]. Eur J Nucl Med Mol Imaging, 2003, 30(6):844-850.
[11] Rajendran JG, Hendrickson KR, Spence AM, et al. Hypoxia imaging-directed radiation treatment planning[J]. Eur J Nucl Med Mol Imaging, 2006, 33(Suppl 1):44-53.
[12] Gagel B, Reinartz P, Demirel C, et al.[18F] fluoromisonidazole and[18F] fluorodeoxyglucose positron emission tomography in response evaluation after chemo-/radiotherapy of non-small-cell lung cancer:a feasibility study[J]. BMC Cancer, 2006, 6:51.
[13] Obata A, Kasamatsu S, Lewis JS, et al. Basic characterization of 64Cu-ATSM as a radiotherapy agent[J]. Nucl Med Biol, 2005, 32(1):21-28.
[14] Dehdashti F, Mintun MA, Lewis JS, et al. In vivo assessment of tumor hypoxia in lung cancer with 60Cu-ATSM[J]. Eur J Nucl Med Mol imaging, 2003, 30(6):844-850.
[15] Eschmann SM, Paulsen F, Reimold M, et al. Prognostic impact of hypoxia imaging with 18F-misonidazole PET in non-small cell lung cancer and head and neck cancer before radiotherapy[J]. J Nucl Med, 2005, 46(2):253-260.
相似文献/References:
[1]周玉祥,蓝博文,黄春榆,等.64排螺旋CT冠状动脉血管成像诊断冠状动脉-肺动脉瘘的应用价值[J].国际放射医学核医学杂志,2016,40(1):26.[doi:10.3760/cma.j.issn.1673-4114.2016.01.006]
Zhou Yuxiang,Lan Bowen,Huang Chunyu,et al.Clinical value of coronary artery-pulmonary artery fistula revealed by 64-slice spiral CT coronary angiography[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):26.[doi:10.3760/cma.j.issn.1673-4114.2016.01.006]
[2]陈超坤,刘亮,傅飞先,等.囊性胸腺瘤和囊性畸胎瘤的影像学特征及鉴别诊断[J].国际放射医学核医学杂志,2016,40(1):31.[doi:10.3760/cma.j.issn.1673-4114.2016.01.007]
Chen Chaokun,Liu Liang,Fu Feixian,et al.Imaging features and differential diagnosis of cystic thymoma and cystic teratoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):31.[doi:10.3760/cma.j.issn.1673-4114.2016.01.007]
[3]岳进,苏丽萍.全身MRI与PET/CT在淋巴瘤骨髓浸润诊断及预后中的作用[J].国际放射医学核医学杂志,2016,40(1):50.[doi:10.3760/cma.j.issn.1673-4114.2016.01.010]
Yue Jin,Su Lipin.Function of whole-body MRI and PET/CT in the diagnosis and prognosis of lymphoma with bone marrow infiltration[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):50.[doi:10.3760/cma.j.issn.1673-4114.2016.01.010]
[4]张莹莹,王振光,孔艳.PET/CT显像在肺间质纤维化中的应用进展[J].国际放射医学核医学杂志,2016,40(1):55.[doi:10.3760/cma.j.issn.1673-4114.2016.01.011]
Zhang Yingying,Wang Zhenguang,Kong Yan.Application advancement on PET/CT in pulmonary interstitial fibrosis[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):55.[doi:10.3760/cma.j.issn.1673-4114.2016.01.011]
[5]麦卫平,张永林.能谱CT成像在肺癌诊断中的应用研究进展[J].国际放射医学核医学杂志,2016,40(1):77.[doi:10.3760/cma.j.issn.1673-4114.2016.01.015]
Mai Weiping,Zhang Yonglin.Research progress of spectral imaging in the diagnosis of lung cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):77.[doi:10.3760/cma.j.issn.1673-4114.2016.01.015]
[6]史文杰,孟召伟,谭建.基于Deauville标准探讨18F-FDG PET/CT在霍奇金淋巴瘤复发诊断中的应用价值[J].国际放射医学核医学杂志,2016,40(2):120.[doi:10.3760/cma.j.issn.1673-4114.2016.02.007]
Shi Wenjie,Meng Zhaowei,Tan Jian.Value of 18F-FDG PET/CT on diagnosis of Hodgkin lymphoma recurrence using Deauville criterion[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):120.[doi:10.3760/cma.j.issn.1673-4114.2016.02.007]
[7]周翠屏,廖俊杰,何国华,等.原发性肠系膜巨大淋巴结增生症的MSCT表现与病理对照分析[J].国际放射医学核医学杂志,2016,40(3):175.[doi:10.3760/cma.j.issn.1673-4114.2016.03.003]
Zhou Cuiping,Liao Junjie,He Guohua,et al.Primary mesenteric Castleman disease:MSCT findings with histopathologic correlation[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):175.[doi:10.3760/cma.j.issn.1673-4114.2016.03.003]
[8]张巧娜,刘汉东.上颌窦上皮-肌上皮癌的CT表现一例[J].国际放射医学核医学杂志,2016,40(3):237.[doi:10.3760/cma.j.issn.1673-4114.2016.03.015]
[9]尤阳,轩昂,张杰,等.淋巴瘤患者大脑静息葡萄糖代谢改变[J].国际放射医学核医学杂志,2016,40(4):255.[doi:10.3760/cma.j.issn.1673-4114.2016.04.003]
You Yang,Xuan Ang,Zhang Jie,et al.Changes in resting-state brain glucose metabolism in patients with lymphoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):255.[doi:10.3760/cma.j.issn.1673-4114.2016.04.003]
[10]王朋,崔邦平,代文莉,等.18F-FDG PET/CT在前列腺癌中的应用进展[J].国际放射医学核医学杂志,2016,40(4):277.[doi:10.3760/cma.j.issn.1673-4114.2016.04.008]
Wang Peng,Cui Bangping,Dai Wenli,et al.Progress in the application of 18F-FDG PET/CT in prostate cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):277.[doi:10.3760/cma.j.issn.1673-4114.2016.04.008]
[11]陈立,陈跃.分化型甲状腺癌骨转移诊断及疗效评价的核素显像研究进展[J].国际放射医学核医学杂志,2016,40(6):452.[doi:10.3760/cma.j.issn.1673-4114.2016.06.010]
Chen Li,Chen Yue.Diagnosis and evaluation of curative effect progress of radionuclide imaging methods in differentiated thyroid cancer of bone metastases[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):452.[doi:10.3760/cma.j.issn.1673-4114.2016.06.010]
[12]安淑娴,宋少莉,黄钢.放射性核素标记的凋亡显像剂的研究进展[J].国际放射医学核医学杂志,2015,39(6):470.[doi:10.3760/cma.j.issn.1673-4114.2015.06.008]
An Shuxian,Song Shaoli,Huang Gang.Recent advances in apoptosis imaging using radionuclide-labeled tracers[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(5):470.[doi:10.3760/cma.j.issn.1673-4114.2015.06.008]
[13]陶绪长,罗晓文,关晏星.阿德福韦酯所致低血磷性骨软化症治疗前后SPECT骨显像对比一例[J].国际放射医学核医学杂志,2015,39(6):513.[doi:10.3760/cma.j.issn.1673-4114.2015.06.018]
[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(5):513.[doi:10.3760/cma.j.issn.1673-4114.2015.06.018]
[14]成钊汀,朱小华.99Tcm-MIBI显像在甲状旁腺功能亢进症中的应用及进展[J].国际放射医学核医学杂志,2015,39(1):37.[doi:10.3760/cma.j.issn.1673-4114.2015.01.009]
Cheng Zhaoting,Zhu Xiaohua.Application and progress of 99Tcm-MIBI scintieraphy in parathyroidism[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(5):37.[doi:10.3760/cma.j.issn.1673-4114.2015.01.009]
[15]林潇,唐明灯.靶向表皮生长因子受体分子探针研究进展[J].国际放射医学核医学杂志,2015,39(1):85.[doi:10.3760/cma.j.issn.1673-4114.2015.01.018]
Lin Xiao,Tang Mingdeng.Research progresses on molecular probes targeting epidermal growth factor receptor[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(5):85.[doi:10.3760/cma.j.issn.1673-4114.2015.01.018]
[16]刘晓梅,张芳,黄建敏.肿瘤血管生成的SPECT分子显像研究进展[J].国际放射医学核医学杂志,2015,39(2):170.[doi:10.3760/cma.j.issn.1673-4114.2015.02.015]
Liu Xiaomei,Zhang Fang,Huang Jianmin.Research advance on molecular imaging of tumor angiogenesis with SPECT[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(5):170.[doi:10.3760/cma.j.issn.1673-4114.2015.02.015]
[17]刘晋华,张宝牛,赵德善.盆腔融合异位肾一例[J].国际放射医学核医学杂志,2015,39(2):190.[doi:10.3760/cma.j.issn.1673-4114.2015.02.020]
[18]陈明,刘纯,严祥,等.SPECT胃黏膜显像在胃中间横带研究中的价值[J].国际放射医学核医学杂志,2015,39(3):197.[doi:10.3760/cma.j.issn.1673-4114.2015.03.002]
Chen Ming,Liu Chun,Yan Xiang,et al.The value of gastric mucosa SPECT in the study of midgastric transverse band[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(5):197.[doi:10.3760/cma.j.issn.1673-4114.2015.03.002]
[19]刘雪辉,李洪均,于鸿煦.SPECT/CT融合显像对可疑骨转移灶的诊断效能[J].国际放射医学核医学杂志,2015,39(3):201.[doi:10.3760/cma.j.issn.1673-4114.2015.03.003]
Liu Xuehui,Li Hongjun,Yu Hongxu.Diagnostic efficacy of SPECT/CT fusion imaging in assessing possible bone metastases[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(5):201.[doi:10.3760/cma.j.issn.1673-4114.2015.03.003]
[20]郭宵峰,刘建中,孙琦婷.肺通气/灌注平面显像与肺灌注SPECT/CT对肺栓塞诊断价值的对比性研究[J].国际放射医学核医学杂志,2015,39(4):277.[doi:10.3760/cma.j.issn.1673-4114.2015.04.001]
Guo Xiaofeng,Liu Jianzhong,Sun Qiting.Comparative study of pulmonary ventilation/perfusion planar imaging and pulmonary perfusion SPECT combined with low-dose CT in the diagnosis of pulmonary embolism[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(5):277.[doi:10.3760/cma.j.issn.1673-4114.2015.04.001]